hemispherx biopharma inc (HEB:NYSE Amex)
Charles T. Bernhardt CPA, M.B.A.
Interim Chief Financial Officer, Echo Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
Mr. Charles T. Bernhardt, CPA, MBA, has been an Interim Chief Financial Officer of Echo Therapeutics, Inc. since July 16, 2014. Mr. Bernhardt served as the Chief Financial Officer and Chief Accounting Officer of Hemispherx Biopharma, Inc. from January 1, 2009 to December 27, 2013. He served as a Director of Accounting for Healthcare Division of Thomson Reuters from 2006 to 2008. He was responsible for their Healthcare Division's accounting operations as well as the shared ...
One Penn CenterPhone: 215-988-0080
Philadelphia, Pennsylvania 19103
Board Members Memberships*There is no Board Members Memberships data available.
West Chester University of Pennsylvania
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Marijn E. Dekkers Ph.D.||Chairman of Management Board and Chief Executive Officer|
|Alex Gorsky||Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee|
Johnson & Johnson
|Miles D. White||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Severin Schwan Ph.D.||Chief Executive Officer and Director|
Roche Holding AG
|SFr.5.1M||Compensation as of Fiscal Year 2013.|